Ironwood Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $91,592 | $94,396 | $74,877 | $117,553 |
Gross Profit | 91,592 | 93,890 | 74,364 | 117,041 |
EBITDA | 27,295 | 26,852 | 12,702 | 39,295 |
EBIT | 26,788 | 26,346 | 12,189 | 38,783 |
Net Income | 31,092 | -860 | -4,162 | -1,087 |
Net Change In Cash | 91,592 | 94,396 | 74,877 | 117,553 |
Free Cash Flow | 9,869 | 33,407 | 44,917 | 35,623 |
Cash | 88,211 | 105,524 | 121,540 | 92,154 |
Basic Shares | 160,232 | 159,014 | 157,700 | 156,014 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $442,735 | $410,596 | $413,753 | $389,523 |
Gross Profit | 441,160 | 409,178 | 412,230 | 386,387 |
EBITDA | -924,864 | 261,438 | 233,330 | 141,903 |
EBIT | -926,439 | 260,020 | 231,807 | 138,339 |
Net Income | -1,002,239 | 175,065 | 528,448 | 106,176 |
Net Change In Cash | 442,735 | 410,596 | 413,753 | 389,523 |
Cost of Revenue | 36,074 | 257,080 | 185,540 | |
Free Cash Flow | 183,154 | 273,627 | 261,630 | 166,994 |
Cash | 92,154 | 656,203 | 620,129 | 362,564 |
Basic Shares | 155,435 | 186,312 | 164,418 | 160,655 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.02 |
2024-06-30 | -$0.005 |
2024-03-31 | -$0.02 |
2023-12-31 | -$0.01 |
